معرفی
Laura Korhonen serves as a Clinical Lecturer in the Department of Paediatrics and Adolescent Medicine at the University of Turku's Faculty of Medicine, contributing to pediatric healthcare through clinical research and academic engagement at the Kiinamyllynkatu campus in Turku.
Her research program integrates pediatric oncology, neurology, and public health with three core emphases: optimizing acute lymphoblastic leukemia treatment through pharmacological studies (e.g., allopurinol co-administration with mercaptopurine), investigating CNS embryonal tumors with PLAGL amplification using imaging-based evaluations, and examining maternal psychological distress impacts on birth outcomes and infant neurodevelopment via the FinnBrain Birth Cohort Study. She also explores early-life environmental factors in eczema development through multi-cohort epidemiological analyses, reflecting a translational approach bridging clinical practice and population health.
Analysis of her 2022-2025 publications reveals consistent focus on evidence-based pediatric interventions, with dominant themes in leukemia therapy optimization, neuro-oncology of molecularly defined CNS tumors, and prenatal exposure effects on child health. Her work predominantly involves international consortia and Finnish birth cohort collaborations, demonstrating active participation in multi-center clinical trials and epidemiological research networks addressing critical gaps in childhood cancer care and developmental health.
As a key investigator in the FinnBrain Birth Cohort Study, Dr. Korhonen contributes to longitudinal research tracking brain development from pregnancy through infancy. Her affiliations extend to European pediatric oncology networks, facilitating cross-institutional research that advances childhood cancer treatment protocols through shared clinical data and therapeutic innovations.
